The Food and Drugs Authority (FDA) has cautioned Ghanaians over an unapproved antimalarial drug making waves on the market.

A statement intercepted by MetroTVOnline alarmed health workers of the presence of an adulterated antimalarial drug- COMBIART Tablets (Artemether/Lumefantrine 20/120) introduced onto the market.

According to the FDA, samples of the drug it received from the Northern Region lacked two active pharmaceutical ingredients labeled on its container.

“Samples of this drug from the Northern Region did not contain any of the two active pharmaceutical ingredients stated on the label, hence can be classified as falsified,’ the FDA said in the statement.

Howbeit, the FDA has urged the general public to be mindful of the drug and report it to the necessary authority if they come across it.

Details of the drug are as follows;

Batch number: 7225119

Manufacturing date: 03/2021

Expiry date: 02/2024

Manufacturer: Strides Arcolab Ltd.

NAFDAC Registration: A4-6700

By Leonora Enyonam Annoh | Metrotvonline.com | Ghana